IMB-BZ

N/A

Report date: 2023/01/16 11:25:29
NME

Base Information

Drug NameIMB-BZ
Drug Alias NameIMB-BZ
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionESAT-6-like protein EsxB inhibitors
TargetsESAT-6-like protein EsxB
Therapy Area/IndicationsTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesInstitute Of Medical Biotechnology, Chinese Academy Of Medical Sciences
China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Medical Biotechnology, Chinese Academy Of Medical Sciences
Inactive CompaniesN/A
Active IndicationsTuberculosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A